BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 29379961)

  • 1. Review of the Neurological Implications of von Hippel-Lindau Disease.
    Dornbos D; Kim HJ; Butman JA; Lonser RR
    JAMA Neurol; 2018 May; 75(5):620-627. PubMed ID: 29379961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The natural history of hemangioblastomas of the central nervous system in patients with von Hippel-Lindau disease.
    Wanebo JE; Lonser RR; Glenn GM; Oldfield EH
    J Neurosurg; 2003 Jan; 98(1):82-94. PubMed ID: 12546356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurologic manifestations of von Hippel-Lindau disease.
    Butman JA; Linehan WM; Lonser RR
    JAMA; 2008 Sep; 300(11):1334-42. PubMed ID: 18799446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of von Hippel-Lindau disease-associated CNS lesions.
    Wind JJ; Lonser RR
    Expert Rev Neurother; 2011 Oct; 11(10):1433-41. PubMed ID: 21955200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurosurgical treatment of von Hippel-Lindau-associated hemangioblastomas: benefits, risks and outcome.
    Pavesi G; Feletti A; Berlucchi S; Opocher G; Martella M; Murgia A; Scienza R
    J Neurosurg Sci; 2008 Jun; 52(2):29-36. PubMed ID: 18500215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endolymphatic sac tumors. A source of morbid hearing loss in von Hippel-Lindau disease.
    Manski TJ; Heffner DK; Glenn GM; Patronas NJ; Pikus AT; Katz D; Lebovics R; Sledjeski K; Choyke PL; Zbar B; Linehan WM; Oldfield EH
    JAMA; 1997 May; 277(18):1461-6. PubMed ID: 9145719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective natural history study of central nervous system hemangioblastomas in von Hippel-Lindau disease.
    Lonser RR; Butman JA; Huntoon K; Asthagiri AR; Wu T; Bakhtian KD; Chew EY; Zhuang Z; Linehan WM; Oldfield EH
    J Neurosurg; 2014 May; 120(5):1055-62. PubMed ID: 24579662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological and clinical impact of hemangioblastoma-associated peritumoral cysts in von Hippel-Lindau disease.
    Huntoon K; Wu T; Elder JB; Butman JA; Chew EY; Linehan WM; Oldfield EH; Lonser RR
    J Neurosurg; 2016 Apr; 124(4):971-6. PubMed ID: 26517769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumors of the endolymphatic sac in patients with von Hippel-Lindau disease: implications for their natural history, diagnosis, and treatment.
    Kim HJ; Butman JA; Brewer C; Zalewski C; Vortmeyer AO; Glenn G; Oldfield EH; Lonser RR
    J Neurosurg; 2005 Mar; 102(3):503-12. PubMed ID: 15796386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical management of brainstem hemangioblastomas in patients with von Hippel-Lindau disease.
    Weil RJ; Lonser RR; DeVroom HL; Wanebo JE; Oldfield EH
    J Neurosurg; 2003 Jan; 98(1):95-105. PubMed ID: 12546357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemangioblastomas of the central nervous system in von Hippel-Lindau syndrome and sporadic disease.
    Conway JE; Chou D; Clatterbuck RE; Brem H; Long DM; Rigamonti D
    Neurosurgery; 2001 Jan; 48(1):55-62; discussion 62-3. PubMed ID: 11152361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional outcome after resection of spinal cord hemangioblastomas associated with von Hippel-Lindau disease.
    Mehta GU; Asthagiri AR; Bakhtian KD; Auh S; Oldfield EH; Lonser RR
    J Neurosurg Spine; 2010 Mar; 12(3):233-42. PubMed ID: 20192620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of morbid hearing loss associated with tumors of the endolymphatic sac in von Hippel-Lindau disease.
    Butman JA; Kim HJ; Baggenstos M; Ammerman JM; Dambrosia J; Patsalides A; Patronas NJ; Oldfield EH; Lonser RR
    JAMA; 2007 Jul; 298(1):41-8. PubMed ID: 17609489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term natural history of hemangioblastomas in patients with von Hippel-Lindau disease: implications for treatment.
    Ammerman JM; Lonser RR; Dambrosia J; Butman JA; Oldfield EH
    J Neurosurg; 2006 Aug; 105(2):248-55. PubMed ID: 17219830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Personalized Medicine for Nervous System Manifestations of von Hippel-Lindau Disease.
    Schunemann V; Huntoon K; Lonser RR
    Front Surg; 2016; 3():39. PubMed ID: 27446927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical management of cerebellar hemangioblastomas in patients with von Hippel-Lindau disease.
    Jagannathan J; Lonser RR; Smith R; DeVroom HL; Oldfield EH
    J Neurosurg; 2008 Feb; 108(2):210-22. PubMed ID: 18240914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central nervous system hemangioblastomas, endolymphatic sac tumors, and von Hippel-Lindau disease.
    Richard S; David P; Marsot-Dupuch K; Giraud S; Béroud C; Resche F
    Neurosurg Rev; 2000 Mar; 23(1):1-22; discussion 23-4. PubMed ID: 10809480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Von Hippel-Lindau disease germline mutations in Mexican patients with cerebellar hemangioblastoma.
    Rasmussen A; Nava-Salazar S; Yescas P; Alonso E; Revuelta R; Ortiz I; Canizales-Quinteros S; Tusié-Luna MT; López-López M
    J Neurosurg; 2006 Mar; 104(3):389-94. PubMed ID: 16572651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sporadic and Von-Hippel Lindau disease-associated spinal hemangioblastomas: institutional experience on their similarities and differences.
    Yousef A; Rutkowski MJ; Yalcin CE; Eren OC; Caliskan I; Tihan T
    J Neurooncol; 2019 Jul; 143(3):547-552. PubMed ID: 31089924
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.